Tuberous sclerosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Tuberous sclerosis}} {{CMG}} ==Medical Therapy== Drug therapy for some of the manifestations of TSC is currently in the developmental stage.<ref>{{cite journal |...") |
Jose Loyola (talk | contribs) No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Tuberous sclerosis}} | {{Tuberous sclerosis}} | ||
{{CMG}} | {{CMG}} {{AE}} {{Jose}} | ||
== Overview == | |||
Medical therapy is generally preferred over surgical ones due to their fewer number of complications and diminishing side effects over time. | |||
==Medical Therapy== | ==Medical Therapy== | ||
=== Epilepsy === | |||
* Anti-[[seizure]] medications can be prescribed to control [[seizures]]. The preferred medication is [[vigabatrin]]<ref name="pmid19557123">{{cite journal |author=Tsao CY |title=Current trends in the treatment of infantile spasms |journal=Neuropsychiatr Dis Treat |volume=5 |issue= |pages=289–99 |year=2009 |pmid=19557123 |pmc=2695218 |doi= |url=http://www.dovepress.com/articles.php?article_id=3150}}</ref>, but other [[anticonvulsants]], [[clobazam]], [[Ketogenic diet|ketogenic]] diet, or surgical procedures.<ref name=":0">Henske, Elizabeth P., et al. "Tuberous sclerosis complex." ''Nature reviews Disease primers'' 2.1 (2016): 1-18.</ref> Treatment before the onset of [[epilepsy]] and other neuropsychiatric manifestations may be beneficial, but trials testing this approach are still ongoing (EPISTOP trial). [[mTOR]] inhibitors may present with some anti-epileptogenic properties.<ref name=":0" /> | |||
=== Lymphangioleiomyomatosis === | |||
* [[Sirolimus]] should be used in women presenting with TSC-associated [[lymphangioleiomyomatosis]] or sporadic LAM with <70% of the predicted normal FEV1. [[Everolimus]] has also been show to improve these patients' condition.<ref name=":0" /> | |||
=== Angiomyolipoma === | |||
* Treatment is done in a pre-emptive manner to prevent bleeding, reduce tumor size or slow its growth. Systemic [[everolimus]] is the preferred method nowadays but there are also surgical options. <ref name=":0" /> | |||
=== Subependymal Giant Cell Astrocytoma === | |||
* Treatment with [[mTOR]] inhibitors have been recommended, being well tolerated and presenting with side effects that decreases over time.<ref name=":0" /> There are also surgical procedures but they have important complications. | |||
=== Tuberous Sclerosis Complex-associated Neuropsychiatric Disorder === | |||
* There are no specific interventions, patients must be followed closely by a psychiatrist. Trials exploring the use of [[mTOR]] inhibitors for this manifestation are ongoing.<ref name=":0" /> | |||
=== Skin Lesions === | |||
For TSC-associated skin lesions, the following treatments may be performed: | |||
* [[Sunscreen|Sun protection]]; | |||
* "Camouflage make-up" | |||
* Topical mTOR inhibitors. | |||
*There are surgical options and ablation. | |||
=== mTOR Inhibitors side effect: === | |||
mTOR inhibition therapy may cause [[stomatitis]], [[Diabetes mellitus|diabetes]], [[hyperlipidemia]], wound-healing complications, infertility and delayed sexual maturation.<ref name=":0" /> | |||
==References== | ==References== | ||
Latest revision as of 17:58, 23 June 2020
|
Tuberous sclerosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tuberous sclerosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Tuberous sclerosis medical therapy |
|
Risk calculators and risk factors for Tuberous sclerosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: José Eduardo Riceto Loyola Junior, M.D.[2]
Overview
Medical therapy is generally preferred over surgical ones due to their fewer number of complications and diminishing side effects over time.
Medical Therapy
Epilepsy
- Anti-seizure medications can be prescribed to control seizures. The preferred medication is vigabatrin[1], but other anticonvulsants, clobazam, ketogenic diet, or surgical procedures.[2] Treatment before the onset of epilepsy and other neuropsychiatric manifestations may be beneficial, but trials testing this approach are still ongoing (EPISTOP trial). mTOR inhibitors may present with some anti-epileptogenic properties.[2]
Lymphangioleiomyomatosis
- Sirolimus should be used in women presenting with TSC-associated lymphangioleiomyomatosis or sporadic LAM with <70% of the predicted normal FEV1. Everolimus has also been show to improve these patients' condition.[2]
Angiomyolipoma
- Treatment is done in a pre-emptive manner to prevent bleeding, reduce tumor size or slow its growth. Systemic everolimus is the preferred method nowadays but there are also surgical options. [2]
Subependymal Giant Cell Astrocytoma
- Treatment with mTOR inhibitors have been recommended, being well tolerated and presenting with side effects that decreases over time.[2] There are also surgical procedures but they have important complications.
Tuberous Sclerosis Complex-associated Neuropsychiatric Disorder
- There are no specific interventions, patients must be followed closely by a psychiatrist. Trials exploring the use of mTOR inhibitors for this manifestation are ongoing.[2]
Skin Lesions
For TSC-associated skin lesions, the following treatments may be performed:
- Sun protection;
- "Camouflage make-up"
- Topical mTOR inhibitors.
- There are surgical options and ablation.
mTOR Inhibitors side effect:
mTOR inhibition therapy may cause stomatitis, diabetes, hyperlipidemia, wound-healing complications, infertility and delayed sexual maturation.[2]